Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. (300357.SZ)
CNY 21.55
(-0.23%)
CNY 21.55
(-0.23%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 59.03 Million CNY | 21.95% |
| 2022 | 48.41 Million CNY | -9.94% |
| 2021 | 53.75 Million CNY | 11.21% |
| 2020 | 48.33 Million CNY | 31.27% |
| 2019 | 36.81 Million CNY | 56.86% |
| 2018 | 23.47 Million CNY | 18.39% |
| 2017 | 19.82 Million CNY | 41.22% |
| 2016 | 14.04 Million CNY | 53.36% |
| 2015 | 9.15 Million CNY | -23.15% |
| 2014 | 11.91 Million CNY | 49.52% |
| 2013 | 7.96 Million CNY | 58.21% |
| 2012 | 5.03 Million CNY | 9.04% |
| 2011 | 4.61 Million CNY | 28.17% |
| 2010 | 3.6 Million CNY | -4.31% |
| 2009 | 3.76 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q3 | 52.51 Million CNY | -14.97% |
| 2024 Q2 | 61.75 Million CNY | 2.78% |
| 2024 Q1 | 60.08 Million CNY | 1.78% |
| 2023 FY | 59.03 Million CNY | 21.95% |
| 2023 Q3 | 55.39 Million CNY | 4.23% |
| 2023 Q1 | 50.6 Million CNY | 4.53% |
| 2023 Q4 | 59.03 Million CNY | 6.58% |
| 2023 Q2 | 53.14 Million CNY | 5.01% |
| 2022 Q1 | 48.48 Million CNY | -9.79% |
| 2022 FY | 48.41 Million CNY | -9.94% |
| 2022 Q4 | 48.41 Million CNY | 2.37% |
| 2022 Q3 | 47.28 Million CNY | -5.41% |
| 2022 Q2 | 49.99 Million CNY | 3.1% |
| 2021 Q3 | 51.44 Million CNY | 0.48% |
| 2021 Q4 | 53.75 Million CNY | 4.48% |
| 2021 Q2 | 51.19 Million CNY | 2.53% |
| 2021 Q1 | 49.93 Million CNY | 3.31% |
| 2021 FY | 53.75 Million CNY | 11.21% |
| 2020 Q2 | 39.15 Million CNY | -0.31% |
| 2020 Q1 | 39.28 Million CNY | 6.69% |
| 2020 FY | 48.33 Million CNY | 31.27% |
| 2020 Q3 | 36.89 Million CNY | -5.79% |
| 2020 Q4 | 48.33 Million CNY | 31.0% |
| 2019 FY | 36.81 Million CNY | 56.86% |
| 2019 Q4 | 36.81 Million CNY | 19.36% |
| 2019 Q3 | 30.84 Million CNY | 5.54% |
| 2019 Q2 | 29.22 Million CNY | 18.07% |
| 2019 Q1 | 24.75 Million CNY | 5.47% |
| 2018 Q3 | 14.58 Million CNY | -16.03% |
| 2018 Q2 | 17.36 Million CNY | -3.18% |
| 2018 Q1 | 17.93 Million CNY | -9.53% |
| 2018 FY | 23.47 Million CNY | 18.39% |
| 2018 Q4 | 23.47 Million CNY | 60.96% |
| 2017 Q2 | 18.99 Million CNY | 10.91% |
| 2017 Q4 | 19.82 Million CNY | -2.85% |
| 2017 FY | 19.82 Million CNY | 41.22% |
| 2017 Q3 | 20.4 Million CNY | 7.47% |
| 2017 Q1 | 17.12 Million CNY | 21.95% |
| 2016 FY | 14.04 Million CNY | 53.36% |
| 2016 Q2 | 10.99 Million CNY | 4.92% |
| 2016 Q1 | 10.47 Million CNY | 14.44% |
| 2016 Q4 | 14.04 Million CNY | 20.31% |
| 2016 Q3 | 11.67 Million CNY | 6.17% |
| 2015 Q3 | 9.22 Million CNY | -6.04% |
| 2015 Q2 | 9.81 Million CNY | -18.78% |
| 2015 FY | 9.15 Million CNY | -23.15% |
| 2015 Q1 | 12.08 Million CNY | 1.47% |
| 2015 Q4 | 9.15 Million CNY | -0.77% |
| 2014 Q2 | 11.42 Million CNY | 14.82% |
| 2014 Q1 | 9.95 Million CNY | 24.93% |
| 2014 Q4 | 11.91 Million CNY | 6.76% |
| 2014 FY | 11.91 Million CNY | 49.52% |
| 2014 Q3 | 11.15 Million CNY | -2.36% |
| 2013 Q4 | 7.96 Million CNY | 0.0% |
| 2013 Q1 | - CNY | -100.0% |
| 2013 Q2 | 6.16 Million CNY | 0.0% |
| 2013 FY | 7.96 Million CNY | 58.21% |
| 2013 Q3 | - CNY | -100.0% |
| 2012 Q4 | 5.03 Million CNY | 0.0% |
| 2012 FY | 5.03 Million CNY | 9.04% |
| 2011 FY | 4.61 Million CNY | 28.17% |
| 2010 FY | 3.6 Million CNY | -4.31% |
| 2009 FY | 3.76 Million CNY | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Zhejiang Int'l Group Co.,Ltd. | 3.57 Billion CNY | 98.347% |
| Zhejiang Zhenyuan Share Co., Ltd. | 679.41 Million CNY | 91.311% |
| Hunan Jingfeng Pharmaceutical Co.,Ltd. | 64.57 Million CNY | 8.579% |
| Hubei Guangji Pharmaceutical Co., Ltd. | 298.99 Million CNY | 80.254% |
| Yifan Pharmaceutical Co., Ltd. | 928.6 Million CNY | 93.642% |
| Guangdong Jiaying Pharmaceutical Co., Ltd | 84.6 Million CNY | 30.216% |
| Sichuan Kelun Pharmaceutical Co., Ltd. | 3.83 Billion CNY | 98.462% |
| Chongqing Lummy Pharmaceutical Co., Ltd. | 170.99 Million CNY | 65.475% |
| Boai NKY Medical Holdings Ltd. | 309.8 Million CNY | 80.943% |